Evidence map›Paper›PMID 34839747›Full record

ArticleAntiviral chemistry & chemotherapy

Anti-influenza virus activity of the elenolic acid rich olive leaf (

Aurora Salamanca, Paula Almodóvar, Irene Jarama, Daniel González-Hedström, Marin Prodanov, Antonio Manuel Inarejos-García

Open access · hybridAbstract read
In one paragraph

Article in Antiviral chemistry & chemotherapy. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. A comprehensive review ofRSC advances · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Aurora SalamancaPharmactive Biotech Products S.L. Parque Científico de Madrid, Madrid, Spain.
Paula AlmodóvarPharmactive Biotech Products S.L. Parque Científico de Madrid, Madrid, Spain.
Irene JaramaPharmactive Biotech Products S.L. Parque Científico de Madrid, Madrid, Spain.
Daniel González-HedströmPharmactive Biotech Products S.L. Parque Científico de Madrid, Madrid, Spain.ORCID https://orcid.org/0000-0001-9425-1115
Marin ProdanovDepartamento de Química Física Aplicada, Facultad de Ciencias, CIAL (CEI, CSIC-UAM), 16722Universidad Autónoma de Madrid, Madrid, Spain.
Antonio Manuel Inarejos-GarcíaPharmactive Biotech Products S.L. Parque Científico de Madrid, Madrid, Spain.
Universidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Seasonal flu is caused by influenza infection, a virus that spreads easily in human population with periodical epidemic outbreaks. The high mutational rate of influenza viruses leads to the emergence of strains resistant to the current treatments. Due to that, scientific research is focusing on the development of new anti-influenza agents as alternative or complementary treatments. Olive tree (

Indexed as

Influenza, HumanOleaOrthomyxoviridaeAnimalsAntiviral AgentsDogsDrug Resistance, ViralHumansMadin Darby Canine Kidney CellsNeuraminidaseOseltamivirPlant ExtractsPyransAntiviral Agentselenolic acidNeuraminidaseOseltamivirPlant ExtractsPyransantiviral activityelenolic acidinfluenza virusMDCK-SIAT1 cellsneuraminidase inhibition activityOlive leaf extractoseltamivir

Identifiers

PMID34839747
PMCPMC8641117
OpenAlexW3215392626

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.